Clinical Trial: Postprandial Glycemic and GLP-1 Responses to Modified Full-sugar Drinks

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918196) titled 'Postprandial Glycemic and GLP-1 Responses to Modified Full-sugar Drinks' on Oct. 13.

Brief Summary: This randomized, double-blind, crossover study will evaluate postprandial blood glucose and glucagon-like peptide-1 (GLP-1) responses to different sugar-containing beverages in healthy adults. The study will also evaluate whether the addition of epigallocatechin gallate (EGCG), a compound found in green tea, modifies glucose and GLP-1 responses. Participants will complete four study visits and consume a different study beverage at each visit. Blood samples will be collected to measure glucose, GLP-1, and insulin, and participants will ...